If you need more lookups,
subscriptions start at $34 USD/month.
António Parada Location
Porto, PT
António Parada Work
Board Member @ (January 2025 - Present)
Chairman of the Supervisory Board @ EMBLEM (January 2011 - Present)
Chief Executive Officer @ (May 2012 - September 2025)
Board Member @ Centro de Diagnóstico y Estudios Metabólicos Avanzados de Cantabria (CDEMAC) (May 2014 - May 2017)
Member of External Advisory Board @ ERA-NET infecta (January 2013 - November 2016)
General Manager @ IBMC - Instituto de Biologia Molecular e Celular (June 2002 - September 2013)
Manager Clinical trials Unit @ IPO Porto (February 2011 - May 2012)
Site Manager @ (June 2008 - March 2012)
CEO @ BioCodex (June 2002 - December 2008)
Board member @ Bioteca, S.A. (January 2005 - January 2008)
Board member @ Genetest (January 2004 - January 2008)
Vice-President for professional development @ (May 2004 - May 2007)
Scientific Manager @ (September 1994 - May 2002)
António Parada Education
Universidade Católica do Porto
MBA (MBA)
2000-2001
Faculdade de Ciências da Universidade do Porto
(Botany/Plant Biology)
1987-1993
António Parada Skills
Business Strategy
Biotechnology
Ciências da vida
Biotecnologia
Gestão
Start-ups
Clinical Trials
Management
Pharmaceutical Industry
Technology Transfer
Clinical Development
Molecular Biology
Life Sciences
Cancer
Strategy
Drug Discovery
Healthcare
Marketing
Sales
Start Ups
Program Management
António Parada Summary
António Parada, based in Porto, PT, is currently a Board Member at iBio, Inc.. António Parada brings experience from previous roles at EMBLEM, FairJourney Biologics, Centro de Diagnóstico y Estudios Metabólicos Avanzados de Cantabria (CDEMAC) and ERA-NET infecta. António Parada holds a 2000 - 2001 MBA in MBA @ Universidade Católica do Porto. With a robust skill set that includes Business Strategy, Biotechnology, Ciências da vida, Biotecnologia, Gestão and more. António Parada has 2 emails and 5 mobile phone numbers on RocketReach.
Looking for a different António Parada?
Find contact details for 700 million professionals.